Search results
Results From The WOW.Com Content Network
Journal of Neurotrauma reports the latest advances in both the clinical and laboratory investigation of traumatic brain and spinal cord injury. The Journal focuses on the basic pathobiology of injury to the central nervous system, while considering preclinical and clinical trials targeted at improving both the early management and long-term ...
The theory behind the new spinal cord stimulator is that in certain cases of spinal cord injury the spinal nerves between the brain and the legs are still alive, but just dormant. [48] On 1 November 2018 a third distinct research team from the University of Lausanne published similar results with a similar stimulation technique in the journal ...
ASIA is one of the affiliated societies of the International Spinal Cord Society. [6] The exam is based on neurological responses, touch and pinprick sensations tested in each dermatome, and strength of the muscles that control key motions on both sides of the body. [7] Muscle strength is scored on a scale of 0–5 according to the adjacent ...
Approximately 302,000 people in the U.S. are living with a spinal cord injury, with about 18,000 new spinal cord injuries occurring every year, according to the Reeves’ foundation. Still ...
The International Spinal Cord Society (ISCoS) was founded in 1961 as the International Medical Society of Paraplegia. It is an INGO , whose purpose is to study all problems relating to lesions of the spinal cord .
Myelomalacia. Myelomalacia. MRI image shows spinal bleeding (myelomalacia). Myelomalacia is a pathological term referring to the softening of the spinal cord. [1] Possible causes of myelomalacia include cervical myelopathy, hemorrhagic infarction, or acute injury, such as that caused by intervertebral disc extrusion. [2]
The rehabilitation process following a spinal cord injury typically begins in the acute care setting. Occupational therapy plays an important role in the management of SCI. [2] Recent studies emphasize the importance of early occupational therapy, started immediately after the client is stable. This process includes teaching of coping skills ...
The trial aimed to evaluate the drug GRNOPC1, embryonic stem cell-derived oligodendrocyte progenitor cells, on people with acute spinal cord injury. The trial was discontinued in November 2011 so that the company could focus on therapies in the "current environment of capital scarcity and uncertain economic conditions". [25]